Monthly Archives - May 2025

21May

Gene and Cell Therapies in Focus at ASGCT 2025: Tackling Rare Diseases, Autoimmune Conditions, and More

Immusoft, a California-based cell therapy innovator, is presenting the world’s first clinical trial data for engineered B cells targeting mucopolysaccharidosis type I (MPS I), a rare genetic disorder caused by a deficiency in the enzyme iduronidase. This condition triggers a harmful buildup of substances, leading to severe developmental and physical challenges. At ASGCT 2025, Paul J. Orchard, MD, from the University of Minnesota, will share results from a first-in-human trial, highlighting the safety and early efficacy of autologous B cells...
Portfolio News
Read more...
21May

KIOXIA and Wasabi Collaborate to Deliver Fast, Intelligent Cloud Object Storage Solution

SAN JOSE, Calif.--(BUSINESS WIRE)--KIOXIA America, Inc. today announced a collaboration with Wasabi Technologies to enhance the speed, reliability, and cost-efficiency of their cloud object storage offering. Since 2022, KIOXIA has worked closely with Wasabi to provide SAS and NVMeTM SSDs for highly performant cloud storage services. As part of this ongoing collaboration, Wasabi is utilizing high-performance enterprise and data center-class NVMe SSDs from KIOXIA for its Hot Cloud Storage Service. Read More>>
Portfolio News
Read more...
14May

If student loan domino falls, what’s next for fintechs in the sector?

As of last week, following policy changes under the Trump Administration, borrowers may see hits to their credit scores, wages garnished, tax refunds seized, and reductions in social security benefits. To make sense of how these changes may affect student loan-focused fintechs, as well as their impact on the debt and financial health of US consumers, we interviewed Laurel Taylor, Founder and CEO of NYC-based student debt and savings optimization platform Candidly. Read More>>
Portfolio News
Read more...